Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02143492
What this trial is testing

Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC

Who this might be right for
Kidney CancerRenal Cell CarcinomaAdvanced Renal Cell Carcinoma
Argos Therapeutics 11
Not applicableStudy completedNCT06607809
What this trial is testing

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Testing effectiveness (Phase 2)Study completedNCT00003914
What this trial is testing

Dolastatin 10 in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Mayo Clinic 30
Testing effectiveness (Phase 2)UnknownNCT02446795
What this trial is testing

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Consorzio Oncotech 104
Post-approval studies (Phase 4)Looking for participantsNCT05805436
What this trial is testing

Preop Laxatives in Robotic Urologic Surgery

Who this might be right for
Prostate CancerKidney CancerConstipation
Chad R. Tracy 240
Early research (Phase 1)Study completedNCT01331135
What this trial is testing

Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors

Who this might be right for
Ewing's SarcomaOsteosarcomaAstrocytoma+13 more
Emory University 18
Early research (Phase 1)Active Not RecruitingNCT05704985
What this trial is testing

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Who this might be right for
CancerSolid TumorColorectal Cancer+6 more
DEKA Biosciences 39
Not applicableStudy completedNCT00927043
What this trial is testing

Study Evaluating Renal Cell Carcinoma Risk Factors

Who this might be right for
Carcinoma, Renal Cell
Pfizer 145
Testing effectiveness (Phase 2)Study completedNCT01517243
What this trial is testing

Phase II Study of Alternating Sunitinib and Temsirolimus

Who this might be right for
Metastatic Renal Cell Carcinoma
Dartmouth-Hitchcock Medical Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT06949215
What this trial is testing

68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision

Who this might be right for
ccRCCComplex Renal Cyst
Peking Union Medical College Hospital 70
Testing effectiveness (Phase 2)UnknownNCT03736330
What this trial is testing

Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma

Who this might be right for
Renal Cancer Metastatic
Sun Yat-sen University 24
Early research (Phase 1)Study completedNCT03502330
What this trial is testing

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

Who this might be right for
Advanced MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Yale University 42
Testing effectiveness (Phase 2)Study completedNCT00678119
What this trial is testing

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

Who this might be right for
Renal Cell Carcinoma
Argos Therapeutics 25
Not applicableStudy completedNCT07004426
What this trial is testing

Symptomatic and Incidental RCC Detection

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Benign Renal NeoplasmRenal Carcinoma
Charles University, Czech Republic 1,000
Early research (Phase 1)Study completedNCT00753415
What this trial is testing

V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Who this might be right for
Non-Small Cell Lung CarcinomaBreast CancerMelanoma+5 more
Merck Sharp & Dohme LLC 37
Not applicableLooking for participantsNCT07327489
What this trial is testing

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Who this might be right for
CancerImmunotherapyAdvanced Solid Tumors Cancer+12 more
Elephas 2,000
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Not applicableNot Yet RecruitingNCT07324876
What this trial is testing

Real-World Study on TKI Therapy After Progression on First-Line TKI/IO Therapy or TKI/IO Therapy After Progression on First-Line TKI in Chinese Patients With Metastatic Renal Cell Carcinoma (mRCC)

Who this might be right for
RCC
Tianjin Medical University Cancer Institute and Hospital 860
Not applicableStudy completedNCT01328691
What this trial is testing

Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor Thrombus

Who this might be right for
Carcinoma, Renal CellThrombus
Seoul National University Hospital 118
Testing effectiveness (Phase 2)Study completedNCT03200717
What this trial is testing

Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 62
Next Page